CONMED Corporation (CNMD) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $35.12 (+2.80%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| May 1, 2025 | Mike Matson | Needham | $61.00 | +73.7% |
| Oct 4, 2024 | Mike Matson | Needham | $97.00 | +176.2% |
| Apr 25, 2024 | Matt O\'Brien | Piper Sandler | $95.00 | +170.5% |
| Apr 25, 2024 | Mike Matson | Needham | $107.00 | +204.7% |
| Oct 26, 2022 | Matt O'Brien | Piper Sandler | $108.00 | +207.6% |
Top Analysts Covering CNMD
CNMD vs Sector & Market
| Metric | CNMD | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.00 | 2.24 | 2.41 |
| Analyst Count | 6 | 8 | 19 |
| Target Upside | +124.1% | +11474.9% | +17.1% |
| P/E Ratio | 19.11 | 4.01 | 31.98 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $338M | $341M | $343M | 4 |
| 2026-09-30 | $330M | $335M | $340M | 2 |
| 2026-12-31 | $367M | $373M | $379M | 3 |
| 2027-03-31 | $323M | $327M | $333M | 3 |
| 2027-06-30 | $353M | $358M | $364M | 2 |
| 2027-09-30 | $346M | $351M | $357M | 2 |
| 2027-12-31 | $384M | $390M | $396M | 3 |
| 2028-12-31 | $1.52B | $1.52B | $1.52B | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $1.08 | $1.09 | $1.10 | 4 |
| 2026-09-30 | $1.03 | $1.05 | $1.07 | 1 |
| 2026-12-31 | $1.38 | $1.40 | $1.43 | 2 |
| 2027-03-31 | $0.99 | $1.01 | $1.03 | 2 |
| 2027-06-30 | $1.21 | $1.23 | $1.26 | 1 |
| 2027-09-30 | $1.16 | $1.19 | $1.21 | 1 |
| 2027-12-31 | $1.50 | $1.53 | $1.56 | 2 |
| 2028-12-31 | $5.49 | $5.55 | $5.62 | 1 |
Frequently Asked Questions
What is the analyst consensus for CNMD?
The consensus among 6 analysts covering CONMED Corporation (CNMD) is Hold with an average price target of $78.00.
What is the highest price target for CNMD?
The highest price target for CNMD is $108.00, set by Matt O'Brien at Piper Sandler on 2022-10-26.
What is the lowest price target for CNMD?
The lowest price target for CNMD is $61.00, set by Mike Matson at Needham on 2025-05-01.
How many analysts cover CNMD?
6 analysts have issued ratings for CONMED Corporation in the past 12 months.
Is CNMD a buy or sell right now?
Based on 6 analyst ratings, CNMD has a consensus rating of Hold (3.00/5) with a +124.1% upside to the consensus target of $78.00.
What are the earnings estimates for CNMD?
Analysts estimate CNMD will report EPS of $1.09 for the period ending 2026-06-30, with revenue estimated at $341M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.